C20:5 w-3
5,8,11,14,17-Eicosapentaenoic Acid
EPA Clear liquid. PROTECT FROM LIGHT. PACKAGED UNDER INERT GAS. Cell permeable. Shown to have a beneficial effect in cardiovascular diseases and inflammation. Causes elevation of intracellular free Ca2+. Inhibits 5-lipoxygenase and reduces thromboxane A2 production and blood viscosity. Reported to induce apoptosis in pancreatic cancer cell lines and to inhibit liver metastasis. Purity: ≥99% by GC. RTECS JX3820000, CAS 10417-94-4. Merck Index: 14, 3531
Ref.: Iwamoto, S., et al. 1998. Nutr. Cancer 31, 143. Lai, P.B., et al. 1996. Br. J. Cancer 74, 1375. Marotta, F., et al. 1995. Digestion 56, 46. Kurihara, T., et al. 1994. Clin. Ther. 16, 830. Okuda, Y., et al. 1994. Biochem. Med. Metab. Biol. 51, 166. James, M.J., et al. 1993. J. Exp. Med. 178, 2261. chamcock, J.S., et al. 1992. Mol. Cell. Biochem. 116, 19. Stenson, W.F., et al. 1992. Ann. Intern. Med. 116, 609. |
